CapsoVision (CV) EPS (Weighted Average and Diluted) (2024 - 2025)
CapsoVision recorded quarterly EPS (Weighted Average and Diluted) of $0.02 in Q4 2025, up 111.76% quarter-over-quarter from -$0.17 in Q3 2025, and up 100.91% year-over-year from $0.01 in Q4 2024.
CapsoVision's EPS (Weighted Average and Diluted) history runs 2 years deep, the most recent figure standing at $0.02 for Q4 2025.
- In Q4 2025, EPS (Weighted Average and Diluted) rose 100.91% year-over-year to $0.02; the TTM figure through Dec 2025 stood at -$4.37 (changed N/A YoY), while the FY2025 annual figure was -$1.03, up 89.54% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.02 for Q4 2025 at CapsoVision, up from -$0.17 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q4 2025 to a low of -$2.79 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -2.02 |
| Dec 31, 2024 | -2.20 |
| Sep 30, 2024 | -2.79 |
| Jun 30, 2024 | -2.58 |